News

Deal Announcements

Adimab Accepts Third Venture Capital Funding

Monday, November 24, 2008 5:58:00 AM PDT | VentureDeal Staff
Lebanon, New Hampshire  --  Biotechnology company Adimab announced that it has secured an undisclosed sum in new venture capital funding.

Adimab says that it is "developing a platform that's deliberately engineered to minimize and potentially eliminate third-party royalties."

Investors in the round were OrbiMed, Borealis Ventures, SV Life Sciences and Polaris Venture Partners. The company said that proceeds from the financing would be used to increase its capacity for "conducting multiple parallel discovery programs."

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1